Clinical Trial Update: D-0120 Safety and PK/PD Study in China [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 safety and PK/PD trial of D-0120 completed in China for hyperuricemia or gout.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• D-0120

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Hyperuricemia or Gout | Phase 1, Phase 2 | Status: COMPLETED